Literature DB >> 6969573

Characterization of three different beta-lactamases from the Bacteroides fragilis group.

B Olsson-Liljequist, K Dornbusch, C E Nord.   

Abstract

beta-Lactamases from five strains of Bacteroides fragilis and two strains of Bacteroides uniformis, all resistant to beta-lactam antibiotics, were compared by means of isoelectric focusing and enzyme kinetic measurements. beta-Lactamases from the five B. fragilis strains were identical, whereas those from the two B. uniformis strains were distinguished from each other and also from the B. fragilis enzymes. The two B. uniformis strains were relatively resistant to cefoxitin (minimal inhibitory concentration, 32 micrograms/ml), but only one of the strains, B. uniformis 2986, was found to rapidly inactivate cefoxitin. This apparently enzymatic inactivation of cefoxitin seemed to be of minor importance, and the main factor for cefoxitin resistance was considered to be a decreased permeability of the drug. Transfer of resistance to beta-lactam antibiotics from these beta-lactamase-producing strains of B. fragilis and B. uniformis to a non-beta-lactamase-producing strain of Bacteroides distasonis was attempted, but with these isolates no transfer of resistance to beta-lactam antibiotics was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969573      PMCID: PMC283974          DOI: 10.1128/AAC.18.2.220

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  [Purification of beta-lactamases by affinity chromatography].

Authors:  F Le Goffic; J Andrillon-Spiegel; R Letarte
Journal:  Biochimie       Date:  1975       Impact factor: 4.079

2.  Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis.

Authors:  K Dornbusch; C E Nord; B Olsson
Journal:  Scand J Infect Dis       Date:  1975

3.  Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity.

Authors:  B Olsson; C E Nord; T Wadström
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Isolation and characterization of several cryptic plasmids from clinical isolates of Bacteroides fragilis.

Authors:  P W Stiffler; R Keller; N Traub
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Characterisation of a -lactamase obtained from a strain of Bacteroides fragilis resistant to -lactam antibiotics.

Authors:  J D Anderson; R B Sykes
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

6.  A rapid method for isoelectric focusing in polyacrylamide gel.

Authors:  J Söderholm; P Allestam; T Wadström
Journal:  FEBS Lett       Date:  1972-07-15       Impact factor: 4.124

7.  Isolation of plasmid deoxyribonucleic acid from two strains of Bacteroides.

Authors:  D G Guiney; C E Davis
Journal:  J Bacteriol       Date:  1975-10       Impact factor: 3.490

8.  A rapid method for the purification of beta-lactamase from Bacillus cereus by affinity chromatography.

Authors:  R G Coombe; A M George
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

9.  Extrachromosomal elements in a variety of strains representing the Bacteroides fragilis group of organisms.

Authors:  W H Tinnell; F L Macrina
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

10.  Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Authors:  H R Onishi; D R Daoust; S B Zimmerman; D Hendlin; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

View more
  16 in total

Review 1.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Current antimicrobial therapy of anaerobic infections.

Authors:  C V Sanders; K E Aldridge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

4.  Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.

Authors: 
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole.

Authors:  K Tunér; C E Nord
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.

Authors:  M A Crosby; D W Gump
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.

Authors:  K E Aldridge; N Morice; D D Schiro
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Properties of novel beta-lactamase produced by Bacteroides fragilis.

Authors:  A Yotsuji; S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

10.  Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum.

Authors:  K Tunér; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.